PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30206554-9	2018	Conventional therapy of HLA-B27-associated AAU with local or systemic glucocorticoids and immunosuppressive drugs (sulfasalazine, methotrexate, azathioprine, etc.)	Azathioprine	144-156	major histocompatibility complex, class I, B	Homo sapiens	24-31	
31427963-12	2019	Indicatively, pre-emptive HLA-B*5701 and TPMT testing before administration of abacavir and azathioprine, respectively, is reimbursed by Medicare based on both economic and efficacy evidence.	Azathioprine	92-104	major histocompatibility complex, class I, B	Homo sapiens	26-31	
9641508-6	1998	Of the 101 patients treated with azathioprine, two out of 15 in remission were HLA B27 positive, whereas as many as 41 out of 86 with still active disease were HLA B27 positive (p = 0.013).	Azathioprine	33-45	major histocompatibility complex, class I, B	Homo sapiens	79-86	
9336428-0	1997	Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis.	Azathioprine	0-12	major histocompatibility complex, class I, B	Homo sapiens	148-155	
9336428-2	1997	We describe a 14-year-old girl with HLA-B27+ spondylarthritis who was treated with AZA 3 mg/kg/day and who suddenly developed severe pancytopenia in the seventh week of treatment.	Azathioprine	83-86	major histocompatibility complex, class I, B	Homo sapiens	36-43